C-Cbl regulates glioma invasion through matrix metalloproteinase 2

Journal of Cellular Biochemistry

Volumn 111, Issue 5, 2010, Pages 1169-1178

  Lee, Hojin ^a,b   Tsygankov, Alexander Y ^a  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

c Cbl; glioma; invasion; MMP2

Indexed keywords

CBL PROTEIN; GELATINASE A;

ARTICLE; CANCER INVASION; CELL ADHESION; CELL INVASION; CELL LINE; CELL MIGRATION; CYTOSKELETON; DEGRADATION; DEPLETION; EXTRACELLULAR MATRIX; GLIOMA; GLIOMA CELL; HUMAN; HUMAN CELL; MUTANT; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RNA INTERFERENCE; UPREGULATION; WILD TYPE;

CELL ADHESION; CELL MOVEMENT; GLIOMA; HUMANS; MATRIX METALLOPROTEINASE 2; NEOPLASM INVASIVENESS; PROTO-ONCOGENE PROTEINS C-CBL; RECEPTOR, EPIDERMAL GROWTH FACTOR; UP-REGULATION;

EID: 78649892974     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.22839     Document Type: Article

References (50)

1. Bajetto A, Barbieri F, Dorcaratto A, Barbero S, Daga A, Porcile C, Ravetti JL, Zona G, Spaziante R, Corte G, Schettini G, Florio T,. 2006. Expression of CXC chemokine receptors 1-5 and their ligands in human glioma tissues: Role of CXCR4 and SDF1 in glioma cell proliferation and migration. Neurochem Int 49: 423-432.
2. Bianco R, Troiani T, Tortora G, Ciardiello F,. 2005. Intrinsic and acquired resistance to EGFR inhibitors in human cancer therapy. Endocr Relat Cancer 12 (Suppl 1): S159-S171.
3. Caveggion E, Continolo S, Pixley FJ, Stanley ER, Bowtell DD, Lowell CA, Berton G,. 2003. Expression and tyrosine phosphorylation of Cbl regulates macrophage chemokinetic and chemotactic movement. J Cell Physiol 195: 276-289.
4. Cestra G, Toomre D, Chang S, De Camilli P,. 2005. The Abl/Arg substrate ArgBP2/nArgBP2 coordinates the function of multiple regulatory mechanisms converging on the actin cytoskeleton. Proc Natl Acad Sci USA 102: 1731-1736.
5. Chiusaroli R, Sanjay A, Henriksen K, Engsig MT, Horne WC, Gu H, Baron R,. 2003. Deletion of the gene encoding c-Cbl alters the ability of osteoclasts to migrate, delaying resorption and ossification of cartilage during the development of long bones. Dev Biol 261: 537-547.
6. Deryugina EI, Ratnikov B, Monosov E, Postnova TI, DiScipio R, Smith JW, Strongin AY,. 2001. MT1-MMP initiates activation of pro-MMP-2 and integrin alphavbeta3 promotes maturation of MMP-2 in breast carcinoma cells. Exp Cell Res 263: 209-223.
7. Feshchenko EA, Langdon WY, Tsygankov AY,. 1998. Fyn, Yes, and Syk phosphorylation sites in c-Cbl map to the same tyrosine residues that become phosphorylated in activated T cells. J Biol Chem 273: 8323-8331.
8. Feshchenko EA, Shore SK, Tsygankov AY,. 1999. Tyrosine phosphorylation of C-Cbl facilitates adhesion and spreading while suppressing anchorage- independent growth of V-Abl-transformed NIH3T3 fibroblasts. Oncogene 18: 3703-3715.
9. Hasham MG, Tsygankov AY,. 2004. Tip, an Lck-interacting protein of Herpesvirus saimiri, causes Fas- and Lck-dependent apoptosis of T lymphocytes. Virology 320: 313-329.
10. Hu B, Shi B, Jarzynka MJ, Yiin JJ, D'Souza-Schorey C, Cheng SY,. 2009. ADP-ribosylation factor 6 regulates glioma cell invasion through the IQ-domain GTPase-activating protein 1-Rac1-mediated pathway. Cancer Res 69: 794-801.
11. Huang PH, Xu AM, White FM,. 2009. Oncogenic EGFR signaling networks in glioma. Sci Signal 2: re6.
12. Kleihues P, Louis DN, Scheithauer BW, Rorke LB, Reifenberger G, Burger PC, Cavenee WK,. 2002. The WHO classification of tumors of the nervous system. J Neuropathol Exp Neurol 61: 215-225, discussion 226-229.
13. Koul D, Parthasarathy R, Shen R, Davies MA, Jasser SA, Chintala SK, Rao JS, Sun Y, Benvenisite EN, Liu TJ, Yung WK,. 2001. Suppression of matrix metalloproteinase-2 gene expression and invasion in human glioma cells by MMAC/PTEN. Oncogene 20: 6669-6678.
14. Lee H, Gaughan JP, Tsygankov AY,. 2008. c-Cbl facilitates cytoskeletal effects in v-Abl transformed fibroblast through Rac1- and Rap1-mediated signaling. Int J Biochem Cell Biol 40: 1930-1943.
15. Li B, Chang CM, Yuan M, McKenna WG, Shu HK,. 2003. Resistance to small molecule inhibitors of epidermal growth factor receptor in malignant gliomas. Cancer Res 63: 7443-7450.
16. Lin YM, Jan HJ, Lee CC, Tao HY, Shih YL, Wei HW, Lee HM,. 2008. Dexamethasone reduced invasiveness of human malignant glioblastoma cells through a MAPK phosphatase-1 (MKP-1) dependent mechanism. Eur J Pharmacol 593: 1-9.
17. Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, Jouvet A, Scheithauer BW, Kleihues P,. 2007. The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 114: 97-109.
18. Lund-Johansen M, Bjerkvig R, Humphrey PA, Bigner SH, Bigner DD, Laerum OD,. 1990. Effect of epidermal growth factor on glioma cell growth, migration, and invasion in vitro. Cancer Res 50: 6039-6044.
19. Martin MD, Matrisian LM,. 2007. The other side of MMPs: Protective roles in tumor progression. Cancer Metastasis Rev 26: 717-724.
20. Mellinghoff IK, Wang MY, Vivanco I, Haas-Kogan DA, Zhu S, Dia EQ, Lu KV, Yoshimoto K, Huang JH, Chute DJ, Riggs BL, Horvath S, Liau LM, Cavenee WK, Rao PN, Beroukhim R, Peck TC, Lee JC, Sellers WR, Stokoe D, Prados M, Cloughesy TF, Sawyers CL, Mischel PS,. 2005. Molecular determinants of the response of glioblastomas to EGFR kinase inhibitors. N Engl J Med 353: 2012-2024.
21. Mellinghoff IK, Cloughesy TF, Mischel PS,. 2007. PTEN-mediated resistance to epidermal growth factor receptor kinase inhibitors. Clin Cancer Res 13: 378-381.
22. Meng F, Lowell CA,. 1998. A beta 1 integrin signaling pathway involving Src-family kinases, Cbl and PI-3 kinase is required for macrophage spreading and migration. EMBO J 17: 4391-4403.
23. Nakada M, Nakada S, Demuth T, Tran NL, Hoelzinger DB, Berens ME,. 2007. Molecular targets of glioma invasion. Cell Mol Life Sci 64: 458-478.
24. Naldini L, Blomer U, Gallay P, Ory D, Mulligan R, Gage FH, Verma IM, Trono D,. 1996. In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science 272: 263-267.
25. Nau MM, Lipkowitz S,. 2008. Welcome to the family. In:, Tsygankov A, editor. Cbl proteins. New York: Nova Science Publishers. pp. 3-25.
26. Rao JS,. 2003. Molecular mechanisms of glioma invasiveness: The role of proteases. Nat Rev Cancer 3: 489-501.
27. Rappl A, Piontek G, Schlegel J,. 2008. EGFR-dependent migration of glial cells is mediated by reorganisation of N-cadherin. J Cell Sci 121: 4089-4097.
28. Reddi AL, Duan L, Rainey MA, Ortega-Cava C, Clubb R, Chung BM, Dimri M, Tu C, George M, Raja S, Naramura M, Band V, Band H,. 2008. Cbl-family E3 ubiquitin ligases as regulators of non-receptor tyrosine kinases. In:, Tsygankov A, editor. Cbl proteins. New York: Nova Science Publishers. pp. 53-74.
29. Rubin C, Gur G, Yarden Y,. 2005. Negative regulation of receptor tyrosine kinases: Unexpected links to c-Cbl and receptor ubiquitylation. Cell Res 15: 66-71.
30. Salhia B, Tran NL, Chan A, Wolf A, Nakada M, Rutka F, Ennis M, McDonough WS, Berens ME, Symons M, Rutka JT,. 2008. The guanine nucleotide exchange factors trio, Ect2, and Vav3 mediate the invasive behavior of glioblastoma. Am J Pathol 173: 1828-1838.
31. Sawaya RE, Yamamoto M, Gokaslan ZL, Wang SW, Mohanam S, Fuller GN, McCutcheon IE, Stetler-Stevenson WG, Nicolson GL, Rao JS,. 1996. Expression and localization of 72 kDa type IV collagenase (MMP-2) in human malignant gliomas in vivo. Clin Exp Metastasis 14: 35-42. (Pubitemid 26009753)
32. Scaife RM, Langdon WY,. 2000. c-Cbl localizes to actin lamellae and regulates lamellipodia formation and cell morphology. J Cell Sci 113 (Pt 2): 215-226.
33. Schmidt MH, Dikic I,. 2005. The Cbl interactome and its functions. Nat Rev Mol Cell Biol 6: 907-918.
34. Scott AM, Lee FT, Tebbutt N, Herbertson R, Gill SS, Liu Z, Skrinos E, Murone C, Saunder TH, Chappell B, Papenfuss AT, Poon AM, Hopkins W, Smyth FE, MacGregor D, Cher LM, Jungbluth AA, Ritter G, Brechbiel MW, Murphy R, Burgess AW, Hoffman EW, Johns TG, Old LJ,. 2007. A phase I clinical trial with monoclonal antibody ch806 targeting transitional state and mutant epidermal growth factor receptors. Proc Natl Acad Sci USA 104: 4071-4076.
35. Shao Y, Elly C, Liu YC,. 2003. Negative regulation of Rap1 activation by the Cbl E3 ubiquitin ligase. EMBO Rep 4: 425-431.
36. Stylli SS, Kaye AH, Lock P,. 2008. Invadopodia: At the cutting edge of tumour invasion. J Clin Neurosci 15: 725-737.
37. Suetsugu S, Tezuka T, Morimura T, Hattori M, Mikoshiba K, Yamamoto T, Takenawa T,. 2004. Regulation of actin cytoskeleton by mDab1 through N-WASP and ubiquitination of mDab1. Biochem J 384: 1-8.
38. Swaminathan G, Tsygankov AY,. 2006. The Cbl family proteins: Ring leaders in regulation of cell signaling. J Cell Physiol 209: 21-43.
39. Swaminathan G, Feshchenko EA, Tsygankov AY,. 2007. c-Cbl-facilitated cytoskeletal effects in v-Abl-transformed fibroblasts are regulated by membrane association of c-Cbl. Oncogene 26: 4095-4105.
40. Teckchandani AM, Feshchenko EA, Tsygankov AY,. 2001. c-Cbl facilitates fibronectin matrix production by v-Abl-transformed NIH3T3 cells via activation of small GTPases. Oncogene 20: 1739-1755.
41. Teckchandani AM, Panetti TS, Tsygankov AY,. 2005. c-Cbl regulates migration of v-Abl-transformed NIH 3T3 fibroblasts via Rac1. Exp Cell Res 307: 247-258.
42. Thien CB, Langdon WY,. 2005. c-Cbl and Cbl-b ubiquitin ligases: Substrate diversity and the negative regulation of signalling responses. Biochem J 391: 153-166.
43. Tsygankov A,. 2008. Cbl-family proteins as molecular adaptors. In:, Tsygankov A, editor. Cbl proteins. New York: Nova Science Publishers. pp. 75-98.
44. van den Bent MJ, Brandes AA, Rampling R, Kouwenhoven MC, Kros JM, Carpentier AF, Clement PM, Frenay M, Campone M, Baurain JF, Armand JP, Taphoorn MJ, Tosoni A, Kletzl H, Klughammer B, Lacombe D, Gorlia T,. 2009. Randomized phase II trial of erlotinib versus temozolomide or carmustine in recurrent glioblastoma: EORTC brain tumor group study 26034. J Clin Oncol 27: 1268-1274.
45. Van Meter TE, Broaddus WC, Rooprai HK, Pilkington GJ, Fillmore HL,. 2004. Induction of membrane-type-1 matrix metalloproteinase by epidermal growth factor-mediated signaling in gliomas. Neuro Oncol 6: 188-199.
46. Yamanaka R, Arao T, Yajima N, Tsuchiya N, Homma J, Tanaka R, Sano M, Oide A, Sekijima M, Nishio K,. 2006. Identification of expressed genes characterizing long-term survival in malignant glioma patients. Oncogene 25: 5994-6002.
47. Yeh MW, Rougier JP, Park JW, Duh QY, Wong M, Werb Z, Clark OH,. 2006. Differentiated thyroid cancer cell invasion is regulated through epidermal growth factor receptor-dependent activation of matrix metalloproteinase (MMP)-2/gelatinase A. Endocr Relat Cancer 13: 1173-1183.
48. Young N, Pearl DK, Van Brocklyn JR,. 2009. Sphingosine-1-phosphate regulates glioblastoma cell invasiveness through the urokinase plasminogen activator system and CCN1/Cyr61. Mol Cancer Res 7: 23-32.
49. Zhang W, Shao Y, Fang D, Huang J, Jeon MS, Liu YC,. 2003. Negative regulation of T cell antigen receptor-mediated Crk-L-C3G signaling and cell adhesion by Cbl-b. J Biol Chem 278: 23978-23983.
50. Zhang J, Sarkar S, Yong VW,. 2005. The chemokine stromal cell derived factor-1 (CXCL12) promotes glioma invasiveness through MT2-matrix metalloproteinase. Carcinogenesis 26: 2069-2077.